9 Hrs
Source:
أخبار الصين
Source: أخبار الصين
9 Hrsأخبار الصين
Source: أخبار الصين
9 HrsReady to play
Ready to play
China has added 107 medicines to its national medical insurance drug list and 12 innovative medicines to its commercial insurance list, bringing the latter to 28. The additions include treatments for cancer, rare diseases, chronic conditions and mental health disorders, among them the world’s first genetically engineered T-cell therapy for solid tumors and China’s first gene therapy for hemophilia. The updated lists take effect on January 1, 2027, and the national list now contains 3,331 medicines.
Notice: This Is an AI-Generated Summary
Comments (0)